[PDF][PDF] Outcome of deferred initial therapy in mantle-cell lymphoma
P Martin, A Chadburn, P Christos, K Weil… - J Clin …, 2009 - researchgate.net
P Martin, A Chadburn, P Christos, K Weil, RR Furman, J Ruan, R Elstrom, R Niesvizky, S Ely…
J Clin Oncol, 2009•researchgate.netPurpose Treatment of mantle-cell lymphoma (MCL) is nonstandardized, though patients are
commonly treated immediately at diagnosis. Because data on observation, or “watch and
wait,” have not been previously reported, we analyzed the outcome of deferred initial
therapy.
commonly treated immediately at diagnosis. Because data on observation, or “watch and
wait,” have not been previously reported, we analyzed the outcome of deferred initial
therapy.
Purpose
Treatment of mantle-cell lymphoma (MCL) is nonstandardized, though patients are commonly treated immediately at diagnosis. Because data on observation, or “watch and wait,” have not been previously reported, we analyzed the outcome of deferred initial therapy.
researchgate.net